Zurich, Switzerland: +41 - 43 434 80 33   |   US: (510) 962-8903   |   support@traininng.com

Robert Haslam

Managing Director, Somerset House Consultants

Robert Haslam is a pharmaceutical industry VP with over forty years of experience in Quality Assurance, Production, Development, Clinical Trials and Regulatory Affairs gained in multinational and start-up companies. He is the Managing Director of a consultancy providing quality assurance, manufacturing, development and training support to pharmaceutical companies worldwide. He is an EU ‘Qualified Person’ for marketed and investigational products, including steriles and non-steriles, generics, biopharmaceuticals, herbals. He is also an ISO-qualified Lead Auditor; experienced in EU & FDA Good Manufacturing Practice.

He has extensive experience in GMP audits of drug substance, drug product and Investigational Medicinal Product manufacturers; outsourced activities; supply chain risk management. He has a successful track record of strategic management, facility qualification, designing and implementing quality systems, managing quality remediation programs, product development and outsourcing. He has designed and delivered bespoke GMP training courses to companies worldwide. Expert witness in litigation involving GMP compliance.



No Live Webinars found.




  • Recorded
  • View Anytime
  • ¤155.00
Introduction to Data Integrity in the Pharmaceutical Industry

Data integrity is essential to regulatory compliance within the pharmaceutical industry. This webinar will introduce the recent MHRA, FDA and WHO guidances on data governance and assurance of data integrity.

  • Recorded
  • View Anytime
  • ¤155.00
Introduction to Data Integrity in the Pharmaceutical Industry

Data integrity is essential to regulatory compliance within the pharmaceutical industry. This webinar will introduce the recent MHRA, FDA and WHO guidances on data governance and assurance of data integrity.

300012sem
Robert Haslam
Date: 08 & 09 October, 2018   |   Time: 09:00 AM To 05:00 PM CEST

Computer Systems Validation in the Pharmaceutical Industry, Risk Management & the GAMP®5 Approach

The current GXP regulations focus more and more on the topic of risk management in CSV. This seminar will provide you with guidance in carrying out risk assessments when validating computerized systems.

Price: ¤999.00